Published in Cancer Weekly, February 24th, 2004
"The median age at SCT was 12.6 year (range, 6.2-15 years)," noted M. Ayas and coauthors working at King Faisal Specialist Hospital and Research Center in Riyadh. "Conditioning regimen consisted of cyclophosphamide (CY) 5mg/kg/day i.v. for four days, total body irradiation (TBI) 450cGy in a single dose. Graft-versus-host disease (GVHD) prophylaxis was with cyclosporine and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.